Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

anti-mucin-1/PE immunoconjugate BM7PE

An immunoconjugate containing BM7, a murine monoclonal antibody directed against the human tumor-associated antigen (TAA) mucin-1 (MUC1; MUC-1) covalently linked to the bacterial toxin Pseudomonas exotoxin A (PE), with potential antitumor activity. Upon administration of BM7PE, the antibody moiety targets and binds to MUC1. In turn, the PE moiety inhibits protein synthesis via modifying translation elongation factor 2 (EF-2), thereby causing apoptosis and inhibiting tumor cell growth and proliferation in MUC1-overexressing cancer cells. MUC1, a type I transmembrane protein, is overexpressed in a variety of tumor types. It plays an important role in cancer progression and metastasis.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-MUC1/PE BM7PE
immunotoxin BM7PE
Code name:BM7 PE
BM7-PE
BM7PE
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search